Xeris Biopharma Holdings, Inc. - Common Stock (XERS)
Seasonality Analysis
Xeris Biopharma Holdings, Inc. - Common Stock Annual Seasonality Statistics
Xeris Biopharma Holdings, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | -4.09% | Weak | |
| February | -3.80% | Weak | |
| March | -3.43% | Very Weak | |
| April | 4.38% | Weak | |
| May BEST | 19.66% | Very Strong | |
| June WORST | -7.99% | Very Weak | |
| July | 0.11% | Moderate | |
| August | 17.84% | Very Strong | |
| September | -6.98% | Very Weak | |
| October | 1.48% | Moderate | |
| November | -4.00% | Very Weak | |
| December | 7.06% | Strong |
Xeris Biopharma Holdings, Inc. - Common Stock 2026 vs Historical Pattern
Xeris Biopharma Holdings, Inc. - Common Stock Interactive Seasonality Chart
Xeris Biopharma Holdings, Inc. - Common Stock Pattern Scanner
Xeris Biopharma Holdings, Inc. - Common Stock Seasonal Historical Performance
About Xeris Biopharma Holdings, Inc. - Common Stock (XERS) Seasonality
Xeris Biopharma Holdings, Inc. - Common Stock (XERS) has been analyzed using 8 years of historical data to identify seasonal patterns. Classified under Stocks, Xeris Biopharma Holdings, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Xeris Biopharma Holdings, Inc. - Common Stock is historically May, with an average return of 19.66% and a win rate of 71%. Conversely, June tends to be the weakest month, averaging -7.99% return.
Looking at the full calendar year, Xeris Biopharma Holdings, Inc. - Common Stock has an average annual return of 20.26% with an overall monthly win rate of 52.8%. Out of 12 months, 6 typically show positive average returns.
The seasonal pattern for Xeris Biopharma Holdings, Inc. - Common Stock has a consistency score of 39.9 (Poor), based on 9 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Xeris Biopharma Holdings, Inc. - Common Stock Seasonality FAQ
What is the best month to buy Xeris Biopharma Holdings, Inc. - Common Stock (XERS)?
Historically, May has been the best month for Xeris Biopharma Holdings, Inc. - Common Stock, with an average return of 19.66% and a win rate of 71%. However, past performance does not guarantee future results.
What is the worst month for Xeris Biopharma Holdings, Inc. - Common Stock (XERS)?
Based on historical data, June has been the weakest month for Xeris Biopharma Holdings, Inc. - Common Stock, with an average return of -7.99%. This is a historical observation and does not guarantee future results.
How reliable is XERS seasonality data?
The seasonality analysis for Xeris Biopharma Holdings, Inc. - Common Stock is based on 8 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Xeris Biopharma Holdings, Inc. - Common Stock seasonality in my trading?
Use Xeris Biopharma Holdings, Inc. - Common Stock (XERS) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.